Luca Vincenzo Cappelli

MD/PhD, Weill Cornell Medicine
  • Weill Cornell Medicine
  • United States of America

About Luca Vincenzo Cappelli

Post Doc at Weill Cornell Medicine. MD at Sapienza University, Rome.

Intro Content

Contributor Leukemia

Indeterminate and oncogenic potential: CHIP vs CHOP mutations in AML with NPM1 alteration

Deep sequencing of multiple AML-associated genes at disease milestones allows the classification of mutations, detection of molecular residual disease and identification of high-risk patients despite molecular remission in NPM1mut AML.


Channels contributed to:

Behind the Paper